10YR企业会员
发布人:长沙上禾生物科技有限公司
发布日期:2026/7/24 21:31:22
公司官网 http://www.staherb.com/ 资质:HALAL, KOSHER等认证
☎:19573130018 杨经理(微信同号)
1. 医药与临床研究(核心基本盘)
升白细胞(日本 PMDA 自 1950s 经典获批):盐酸千金藤素片(Cepharanthin®)用于放化疗、苯中毒、药物性白细胞减少症/粒细胞缺乏辅助;伴血小板减少性紫癜、放疗后口腔黏膜炎探索。
抗病毒新药研发:抗 SARS-CoV-2(IC₅₀≈1.90 μM)、流感、HIV-1、登革、冠状病毒属;用于抗病毒 NCE 筛选与老药新用(drug repurposing)管线。
抗肿瘤与 MDR 逆转:联合化疗增敏(抑 P-gp/MRP 外排)、放疗增敏、自噬调节;用于肝癌、肺癌、乳腺癌等辅助方案探索。
抗炎免疫与纤维化:脓毒症、慢性免疫性血小板减少、肺/肝纤维化、放射性肺损伤背景研究。
2. 科研试剂(Research Reagent)
病毒学、免疫学、血液学、肿瘤药理学关键工具化合物;20 mg–1 g 高纯单体(HPLC≥98%/99%)供细胞与动物实验,常作 P-gp 外排抑制阳性对照。
3. 保健品 / 功能性食品(Health Products)
免疫支持(尤其病毒感染后、放化疗后人群)、抗氧化、舒缓过敏背景配方;非治疗宣称,按膳食补充剂原料报关。
4. 化妆品原料(Cosmetic Ingredient)
抗氧、清除自由基、膜稳定、光老化防护、过敏性皮炎/口腔炎舒缓等背景性添加(亲脂阳离子利于透皮)。
5. 传统/旧适应症背景(非主线)
抗疟、治蛇咬、斑秃(日本旧说明书)、口干症(xerostomia)等历史用途,仅作文献背景,不列入现代主推场景。
合规边界:Staherb 供货口径中,“医药原料”指高纯单体供 R&D/API 候选,“保健品/化妆品”属背景性生物活性添加,均不得直接等同药品疗效宣称;出口时按目标国法规区分“API / 科研试剂 / 膳食补充剂原料 / 化妆品原料”四类报关与标签。

1. Pharmaceutical & Clinical Research (core base)
Leukocytosis adjuvant (Japan PMDA-approved since 1950s): Cepharanthine HCl tablets (Cepharanthin®) as adjuvant for leukopenia / agranulocytosis from radio-chemotherapy, benzene or drugs; explored in immune thrombocytopenic purpura and radiation oral mucositis.
Antiviral NCE / repurposing: SARS-CoV-2 (IC₅₀≈1.90 μM, IC₉₀≈4.46 μM), influenza A, HIV-1, dengue, OC43; broad-spectrum antiviral screening and drug-repurposing pipelines.
Oncology & MDR reversal: chemo-sensitizer via ABCB1/P-gp & ABCC10 inhibition, radio-sensitizer, autophagy modulator; adjuvant exploration in liver/lung/breast cancer.
Anti-inflammatory / fibrosis: sepsis, chronic ITP, pulmonary/hepatic fibrosis, radiation lung injury (exploratory).
2. Research Reagent
Key tool compound for virology, immunology, hematology, tumor pharmacology; HPLC ≥98%/99% lots (20 mg–1 g) for in-vitro / in-vivo work; commonly used as positive control for P-gp efflux inhibition.
3. Health Products / Nutraceuticals
Immune support (post-viral, post-chemo/radio), antioxidant, allergy-soothing background formulations; non-treatment claims only, filed as dietary-supplement raw material.
4. Cosmetic Ingredient
Free-radical scavenging, membrane stabilization, photoaging protection, soothing for allergic dermatitis/oral mucositis (lipophilic cation aids transdermal presence).
5. Legacy / traditional indications (non-mainstream)
Antimalarial, snakebite, alopecia areata (old Japanese label), xerostomia — historical context only, not in Staherb’s modern primary scene list.
Compliance note: Staherb supplies “pharma-grade monomer” for R&D/API candidate work; “nutraceutical/cosmetic” grades are background bioactive additions, not equivalent to drug efficacy claims. Export labels split into “API / research reagent / dietary-supplement raw / cosmetic ingredient” per destination regulation.
公司官网 http://www.staherb.com/ 资质:HALAL, KOSHER等认证
☎:19573130018 杨经理(微信同号)
相关新闻资讯